FULC
NASDAQ · Pharmaceuticals
Fulcrum Therapeutics Inc
$7.01
+0.13 (+1.89%)
Open$6.88
Previous Close$6.88
Day High$7.13
Day Low$6.82
52W High$15.74
52W Low$4.78
Volume—
Avg Volume756.0K
Market Cap458.44M
P/E Ratio—
EPS$-0.90
SectorPharmaceuticals
Analyst Ratings
Strong Buy
16 analysts
Price Target
+712.8% upside
Current
$7.01
$7.01
Target
$56.98
$56.98
$37.54
$56.98 avg
$60.88
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 88.39M | 54.89M | 366.88M |
| Net Income | -10,744,616 | -6,005,188 | 47.13M |
| Profit Margin | -12.2% | -11.6% | 12.9% |
| EBITDA | -8,984,663 | -5,300,521 | 69.95M |
| Free Cash Flow | — | — | 54.75M |
| Rev Growth | +61.0% | +61.0% | +22.0% |
| Debt/Equity | — | — | 0.65 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |